share_log

HC Wainwright & Co. Reiterates Buy on Corcept Therapeutics, Maintains $38 Price Target

HC Wainwright & Co. Reiterates Buy on Corcept Therapeutics, Maintains $38 Price Target

HC Wainwright & Co.重申买入Corcept Therapeutics,维持38美元的目标股价
Moomoo 24/7 ·  04/23 13:28

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Corcept Therapeutics (NASDAQ:CORT) with a Buy and maintains $38 price target.

HC Wainwright & Co. 分析师Swayampakula Ramakanth重申了Corcept Therapeutics(纳斯达克股票代码:CORT)的买入并维持38美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发